Jinghua Pharmaceutical Group バランスシートの健全性
財務の健全性 基準チェック /66
Jinghua Pharmaceutical Group has a total shareholder equity of CN¥2.9B and total debt of CN¥25.9M, which brings its debt-to-equity ratio to 0.9%. Its total assets and total liabilities are CN¥3.2B and CN¥319.6M respectively. Jinghua Pharmaceutical Group's EBIT is CN¥261.8M making its interest coverage ratio -7.1. It has cash and short-term investments of CN¥1.2B.
主要情報
0.9%
負債資本比率
CN¥25.92m
負債
| インタレスト・カバレッジ・レシオ | -7.1x |
| 現金 | CN¥1.23b |
| エクイティ | CN¥2.87b |
| 負債合計 | CN¥319.61m |
| 総資産 | CN¥3.19b |
財務の健全性に関する最新情報
Recent updates
財務状況分析
短期負債: 002349's short term assets (CN¥2.0B) exceed its short term liabilities (CN¥301.7M).
長期負債: 002349's short term assets (CN¥2.0B) exceed its long term liabilities (CN¥17.9M).
デット・ツー・エクイティの歴史と分析
負債レベル: 002349 has more cash than its total debt.
負債の削減: 002349's debt to equity ratio has reduced from 20.7% to 0.9% over the past 5 years.
債務返済能力: 002349's debt is well covered by operating cash flow (1112.7%).
インタレストカバレッジ: 002349 earns more interest than it pays, so coverage of interest payments is not a concern.